Medtech a high priority of E700 million EU nanotech drive
This article was originally published in Clinica
Machines no bigger than a molecule will one day surf our blood stream, search and destroy infected tissues and heal our wounds." This is how the European Commission prefaced a pledge to spend E700m ($625m) on nanotechnology research over the next four years, under the forthcoming sixth research framework programme (FP6), in which medical technology promises to take centre stage.
You may also be interested in...
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.